Filippatos Theodosios D, Mikhailidis Dimitri P
Department of Clinical Biochemistry, Vascular Disease Prevention Clinics, Royal Free Hospital Campus, University College London (UCL), London, United Kingdom.
Angiology. 2008 Apr-May;59(2 Suppl):58S-61S. doi: 10.1177/0003319708319643. Epub 2008 May 28.
Retrospective studies show that statin use prevents congestive heart failure and decreases mortality in patients with congestive heart failure; however, only one prospective study is available. In the Controlled Rosuvastatin Multinational Trial in Heart Failure study, rosuvastatin (10 mg/d) was compared with placebo in patients with advanced coronary heart disease-related congestive heart failure. There was no significant difference between rosuvastatin and placebo except for hospitalization rates. Statins must be given to all patients with coronary heart disease as early as possible because they may not work in patients with advanced congestive heart failure.
回顾性研究表明,使用他汀类药物可预防充血性心力衰竭,并降低充血性心力衰竭患者的死亡率;然而,仅有一项前瞻性研究。在心力衰竭中进行的瑞舒伐他汀多中心对照试验研究中,将瑞舒伐他汀(10毫克/天)与安慰剂对患有晚期冠心病相关充血性心力衰竭的患者进行了比较。除住院率外,瑞舒伐他汀与安慰剂之间没有显著差异。必须尽早给所有冠心病患者使用他汀类药物,因为它们可能对晚期充血性心力衰竭患者无效。